432 related articles for article (PubMed ID: 18987350)
1. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.
Mitchell RM; Freeman WM; Randazzo WT; Stephens HE; Beard JL; Simmons Z; Connor JR
Neurology; 2009 Jan; 72(1):14-9. PubMed ID: 18987350
[TBL] [Abstract][Full Text] [Related]
2. Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis.
Su XW; Simmons Z; Mitchell RM; Kong L; Stephens HE; Connor JR
JAMA Neurol; 2013 Dec; 70(12):1505-11. PubMed ID: 24145899
[TBL] [Abstract][Full Text] [Related]
3. Plasma biomarkers associated with ALS and their relationship to iron homeostasis.
Mitchell RM; Simmons Z; Beard JL; Stephens HE; Connor JR
Muscle Nerve; 2010 Jul; 42(1):95-103. PubMed ID: 20544912
[TBL] [Abstract][Full Text] [Related]
4. H63D HFE polymorphisms are associated with increased disease duration and decreased muscle superoxide dismutase-1 expression in amyotrophic lateral sclerosis patients.
Su XW; Lee SY; Mitchell RM; Stephens HE; Simmons Z; Connor JR
Muscle Nerve; 2013 Aug; 48(2):242-6. PubMed ID: 23813494
[TBL] [Abstract][Full Text] [Related]
5. Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences.
Wang XS; Lee S; Simmons Z; Boyer P; Scott K; Liu W; Connor J
J Neurol Sci; 2004 Dec; 227(1):27-33. PubMed ID: 15546588
[TBL] [Abstract][Full Text] [Related]
6. The association between H63D mutations in HFE and amyotrophic lateral sclerosis in a Dutch population.
Sutedja NA; Sinke RJ; Van Vught PW; Van der Linden MW; Wokke JH; Van Duijn CM; Njajou OT; Van der Schouw YT; Veldink JH; Van den Berg LH
Arch Neurol; 2007 Jan; 64(1):63-7. PubMed ID: 17210810
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the HFE gene and sporadic amyotrophic lateral sclerosis risk: a meta-analysis of observational studies.
Li M; Wang L; Wang W; Qi XL; Tang ZY
Braz J Med Biol Res; 2014 Feb; 47(3):215-22. PubMed ID: 24604426
[TBL] [Abstract][Full Text] [Related]
8. Study of the HFE gene common polymorphisms in French patients with sporadic amyotrophic lateral sclerosis.
Praline J; Blasco H; Vourc'h P; Rat V; Gendrot C; Camu W; Andres CR;
J Neurol Sci; 2012 Jun; 317(1-2):58-61. PubMed ID: 22425014
[TBL] [Abstract][Full Text] [Related]
9. HFE p.H63D polymorphism does not influence ALS phenotype and survival.
Chiò A; Mora G; Sabatelli M; Caponnetto C; Lunetta C; Traynor BJ; Johnson JO; Nalls MA; Calvo A; Moglia C; Borghero G; Monsurrò MR; La Bella V; Volanti P; Simone I; Salvi F; Logullo FO; Nilo R; Giannini F; Mandrioli J; Tanel R; Murru MR; Mandich P; Zollino M; Conforti FL; Penco S; ; ; Brunetti M; Barberis M; Restagno G
Neurobiol Aging; 2015 Oct; 36(10):2906.e7-11. PubMed ID: 26174855
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
[TBL] [Abstract][Full Text] [Related]
11. H63D polymorphism in the hemochromatosis gene is associated with sporadic amyotrophic lateral sclerosis in China.
He X; Lu X; Hu J; Xi J; Zhou D; Shang H; Liu L; Zhou H; Yan B; Yu L; Hu F; Liu Z; He L; Yao X; Xu Y
Eur J Neurol; 2011 Feb; 18(2):359-361. PubMed ID: 20642794
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Chitotriosidase and CC-Chemokine Ligand 18 as Biomarkers of Microglia Activation in Amyotrophic Lateral Sclerosis.
Martinez-Merino L; Iridoy M; Galbete A; Roldán M; Rivero A; Acha B; Irún P; Canosa C; Pocoví M; Mendioroz M; Jericó I
Neurodegener Dis; 2018; 18(4):208-215. PubMed ID: 30134252
[TBL] [Abstract][Full Text] [Related]
13. Elevated Levels of IFN-γ in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis.
Liu J; Gao L; Zang D
PLoS One; 2015; 10(9):e0136937. PubMed ID: 26332465
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
[TBL] [Abstract][Full Text] [Related]
15. H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis.
van Rheenen W; Diekstra FP; van Doormaal PT; Seelen M; Kenna K; McLaughlin R; Shatunov A; Czell D; van Es MA; van Vught PW; van Damme P; Smith BN; Waibel S; Schelhaas HJ; van der Kooi AJ; de Visser M; Weber M; Robberecht W; Hardiman O; Shaw PJ; Shaw CE; Morrison KE; Al-Chalabi A; Andersen PM; Ludolph AC; Veldink JH; van den Berg LH
Neurobiol Aging; 2013 May; 34(5):1517.e5-7. PubMed ID: 23063643
[TBL] [Abstract][Full Text] [Related]
16. Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS.
Goodall EF; Greenway MJ; van Marion I; Carroll CB; Hardiman O; Morrison KE
Neurology; 2005 Sep; 65(6):934-7. PubMed ID: 16186539
[TBL] [Abstract][Full Text] [Related]
17. H63D CG genotype of
Zhang QQ; Jiang H; Li CY; Liu YL; Tian XY
J Integr Neurosci; 2020 Sep; 19(3):495-499. PubMed ID: 33070529
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential CSF biomarkers in ALS.
Pasinetti GM; Ungar LH; Lange DJ; Yemul S; Deng H; Yuan X; Brown RH; Cudkowicz ME; Newhall K; Peskind E; Marcus S; Ho L
Neurology; 2006 Apr; 66(8):1218-22. PubMed ID: 16481598
[TBL] [Abstract][Full Text] [Related]
19. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
[TBL] [Abstract][Full Text] [Related]
20. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
